Q U A L I T Y   P L A S M A

Shanghai RAAS differentiated products begin at the source, with the collection of human blood plasma from healthy Chinese donors, immunized with Hepatitis B and Hepatitis A vaccine. All donors are tested to be qualified on the spot, before their plasma is collected by auto–plasmapheresis. All plasma collection centers are approved by the Chinese Ministry of Health (CMOH) and follow strict standard operating procedures approved for use in the United States by the USFDA.


Shanghai RAAS provides newly acquired testing technology as well as continuing quality technical services to these centers. EIA imported test kits, approved by either the USFDA or the Paul Ehrlich Institute of Germany, are used to detect Hepatitis–B surface Antigen (HBsAg), Hepatitis C Virus (Anti-HCV), and Human Immunodeficiency Viruses 1 and 2 (Anti-HIV 1 & 2).